OpenAI, Sam Altman and DeepSeek

Sam Altman says OpenAI will speed up new releases in response to 'invigorating' competition from DeepSeek
Sam Altman hailed the Chinese firm's low-cost AI model as "impressive" and said OpenAI would accelerate the release of "better models" in response.
OpenAI's Sam Altman once warned America about Trump. Now he's partnering with him
OpenAI CEO Sam Altman's decision to join President Trump's "Stargate" AI initiative marks a stark reversal for the tech CEO, who previously was a vocal critic of Trump.
OpenAI CEO Sam Altman responds to DeepSeek AI hype amid widespread stock value crash
OpenAI CEO Sam Altman has responded to the market hype of the recently unveiled DeepSeek AI, which caused tech company stocks to plummet.
OpenAI CEO Sam Altman responds to DeepSeek hype
After the Chinese startup DeepSeek surprised everyone with its AI reasoning model, OpenAI's CEO responded to that hype.
Sam Altman Praises DeepSeek R1 and Promises More From OpenAI
OpenAI Chief Executive Officer Sam Altman welcomed the debut of DeepSeek’s R1 model in a post on X late on Monday.
OpenAI’s Sam Altman calls DeepSeek model ‘impressive’
OpenAI CEO and co-founder Sam Altman called Chinese artificial intelligence startup DeepSeek “impressive,” while shrugging off concerns the startup could threaten OpenAI’s
'Totally hopeless to compete with us': Sam Altman's old video resurfaces and goes viral amid Deepseek's rise
OpenAI founder Sam Altman is facing criticism online after an old video of him resurfaced, in which he dismissed the idea of building a competitive AI model on a $10 million budget as "hopeless." The clip,
Sam Altman Speaks Out on China's DeepSeek AI
OpenAI CEO Sam Altman said that it was "invigorating" to have new competition in the AI industry with DeepSeek's emergence.
DeepSeek jolt: OpenAI's Sam Altman promises 'much better' models
OpenAI CEO Sam Altman said the AI startup will release better models than those of China's DeepSeek, whose powerful low-cost AI model triggered a tech selloff in the U.S. and called into question Silicon Valley's lead in the global AI race.
'Impressive': OpenAI CEO Sam Altman's First Reaction As DeepSeek Sends Global Markets Tumbling
Sam Altman, the CEO of OpenAI has finally opened up on the Chinese Artificial Intelligence (AI) startup DeepSeek and he thinks that DeepSeek R1 is an "impressive model."The OpenAI CEO took to posting on X,
Sam Altman's latest pitch to cozy up with the US government: ChatGPT Gov
Sam Altman's OpenAI launched ChatGPT Gov on Tuesday, which the company said government agencies could use to input sensitive ...
Observer7h
Sam Altman’s $5.4B Nuclear Fusion Startup Helion Baffles Science Community
Helion’s nuclear fusion promises have garnered the attention of Silicon Valley—and raised concerns amongst scientists wary of ...
You can try, but not possible to build AI with $10M: Sam Altman’s old video goes viral after DeepSeek does it with $5M
Chinese AI startup DeepSeek has taken the tech world by storm with its cost-effective, high-performance chatbot, which was ...
Sam Altman Says He's Changed His Mind on Donald Trump
Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.
Sam Altman-Elon Musk Feud Timeline: AI Billionaires Bark Over Trump-Endorsed Stargate AI Project
Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.
Sam Altman touts OpenAI-Microsoft alliance, says next phase will be 'better than anyone is ready for'
OpenAI CEO Sam Altman posted a picture of himself with Microsoft CEO Satya Nadella on Tuesday and suggested the two companies ...
'Better Than Before': OpenAI's Sam Altman Ups The Ante In AI War After DeepSeek Frenzy, Shares A Post Microsoft's Satya Nadella
In his latest post X, Sam Altman shared a symbolically important post. Altman shared a post, which carried a photograph of ...
Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...